Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.244 EGP
173.14 M EGP
33.95 B EGP
582.95 M
About IBNSINA PHARMA
Sector
Industry
Headquarters
Obour City
Website
Founded
2000
ISIN
EGS512O1C012
FIGI
BBG00HRWYZ07
Ibnsina Pharma engages in storage, supply and distribution of pharmaceutical & cosmetic products. It provides its services to pharmacies, hospitals and retailers. The company was founded ion December 18, 2000 and is headquartered in Obour City, Egypt.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ISPH is 5.400 EGP — it has decreased by −1.27% in the past 24 hours. Watch IBNSINA PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange IBNSINA PHARMA stocks are traded under the ticker ISPH.
ISPH stock has fallen by −0.18% compared to the previous week, the month change is a 2.64% rise, over the last year IBNSINA PHARMA has showed a 104.55% increase.
We've gathered analysts' opinions on IBNSINA PHARMA future price: according to them, ISPH price has a max estimate of 9.10 EGP and a min estimate of 8.00 EGP. Watch ISPH chart and read a more detailed IBNSINA PHARMA stock forecast: see what analysts think of IBNSINA PHARMA and suggest that you do with its stocks.
ISPH reached its all-time high on Mar 7, 2019 with the price of 8.767 EGP, and its all-time low was 1.101 EGP and was reached on Jul 5, 2022. View more price dynamics on ISPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ISPH stock is 2.41% volatile and has beta coefficient of 0.64. Track IBNSINA PHARMA stock price on the chart and check out the list of the most volatile stocks — is IBNSINA PHARMA there?
Today IBNSINA PHARMA has the market capitalization of 6.10 B, it has decreased by −2.85% over the last week.
Yes, you can track IBNSINA PHARMA financials in yearly and quarterly reports right on TradingView.
IBNSINA PHARMA is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
ISPH net income for the last quarter is 100.00 M EGP, while the quarter before that showed 79.50 M EGP of net income which accounts for 25.79% change. Track more IBNSINA PHARMA financial stats to get the full picture.
IBNSINA PHARMA dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IBNSINA PHARMA EBITDA is 1.71 B EGP, and current EBITDA margin is 4.01%. See more stats in IBNSINA PHARMA financial statements.
Like other stocks, ISPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IBNSINA PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IBNSINA PHARMA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IBNSINA PHARMA stock shows the buy signal. See more of IBNSINA PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.